HRP20010117B1 - Novel salt form of pantoprazole - Google Patents

Novel salt form of pantoprazole

Info

Publication number
HRP20010117B1
HRP20010117B1 HR20010117A HRP20010117A HRP20010117B1 HR P20010117 B1 HRP20010117 B1 HR P20010117B1 HR 20010117 A HR20010117 A HR 20010117A HR P20010117 A HRP20010117 A HR P20010117A HR P20010117 B1 HRP20010117 B1 HR P20010117B1
Authority
HR
Croatia
Prior art keywords
pantoprazole
salt form
novel salt
novel
compound
Prior art date
Application number
HR20010117A
Other languages
English (en)
Croatian (hr)
Inventor
Kohl Bernhard
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010117(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of HRP20010117A2 publication Critical patent/HRP20010117A2/hr
Publication of HRP20010117B1 publication Critical patent/HRP20010117B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HR20010117A 1998-08-18 2001-02-16 Novel salt form of pantoprazole HRP20010117B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (2)

Publication Number Publication Date
HRP20010117A2 HRP20010117A2 (en) 2002-02-28
HRP20010117B1 true HRP20010117B1 (en) 2010-07-31

Family

ID=7881823

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010117A HRP20010117B1 (en) 1998-08-18 2001-02-16 Novel salt form of pantoprazole

Country Status (33)

Country Link
US (2) US6410569B1 (me)
EP (1) EP1105386B1 (me)
JP (1) JP2002523411A (me)
KR (1) KR100657835B1 (me)
CN (1) CN1146558C (me)
AT (1) ATE219074T1 (me)
AU (1) AU761715B2 (me)
BG (1) BG65255B1 (me)
BR (1) BR9914288A (me)
CA (1) CA2341031C (me)
CZ (1) CZ293734B6 (me)
DE (3) DE19843413C1 (me)
DK (1) DK1105386T3 (me)
EA (1) EA004431B1 (me)
EE (1) EE04278B1 (me)
ES (1) ES2178896T3 (me)
HK (1) HK1037616A1 (me)
HR (1) HRP20010117B1 (me)
HU (1) HU226618B1 (me)
IL (3) IL141328A0 (me)
ME (1) ME00562B (me)
MX (1) MXPA01001758A (me)
NO (1) NO319782B1 (me)
NZ (1) NZ509761A (me)
PL (1) PL198801B1 (me)
PT (1) PT1105386E (me)
RS (1) RS50071B (me)
SI (1) SI1105386T1 (me)
SK (1) SK285105B6 (me)
TR (1) TR200100287T2 (me)
UA (1) UA58605C2 (me)
WO (1) WO2000010995A1 (me)
ZA (1) ZA200100934B (me)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
MXPA05011699A (es) * 2003-05-06 2006-01-23 Altana Pharma Ag Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
US20050004172A1 (en) * 2003-05-19 2005-01-06 Pliva-Istrazivacki Institut D.O.O. Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes
US7683177B2 (en) 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
SI1651217T1 (sl) * 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074929A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
EP1716136A1 (en) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
ES2376466T3 (es) * 2004-05-07 2012-03-14 Nycomed Gmbh Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
US20080177076A1 (en) * 2006-11-06 2008-07-24 Lilach Hedvanti Processes for preparing substantially pure pantoprazole magnesium
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166287A1 (de) * 1984-06-16 1986-01-02 Byk Gulden Lomberg Chemische Fabrik GmbH Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
WO1991019710A1 (de) * 1990-06-11 1991-12-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue salzform
WO1995001977A1 (en) * 1993-07-09 1995-01-19 Astra Aktiebolag Magnesium omeprazole
EP0589981B1 (de) * 1991-06-17 1996-10-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Pantoprazol enthaltende orale darreichungsformen
WO1997041114A1 (en) * 1996-04-26 1997-11-06 Astra Aktiebolag Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166287A1 (de) * 1984-06-16 1986-01-02 Byk Gulden Lomberg Chemische Fabrik GmbH Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
WO1991019710A1 (de) * 1990-06-11 1991-12-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue salzform
EP0589981B1 (de) * 1991-06-17 1996-10-23 Byk Gulden Lomberg Chemische Fabrik Gmbh Pantoprazol enthaltende orale darreichungsformen
WO1995001977A1 (en) * 1993-07-09 1995-01-19 Astra Aktiebolag Magnesium omeprazole
WO1997041114A1 (en) * 1996-04-26 1997-11-06 Astra Aktiebolag Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle

Also Published As

Publication number Publication date
PL345993A1 (en) 2002-01-14
HUP0103257A3 (en) 2003-01-28
TR200100287T2 (tr) 2001-07-23
KR20010072487A (ko) 2001-07-31
DE122005000049I2 (de) 2007-03-29
DE122005000049I1 (de) 2006-12-28
EE200100054A (et) 2002-06-17
HUP0103257A2 (hu) 2002-02-28
EP1105386A1 (en) 2001-06-13
BG105173A (en) 2001-11-30
DE69901840D1 (de) 2002-07-18
EA200100208A1 (ru) 2001-08-27
BR9914288A (pt) 2001-06-19
CN1318065A (zh) 2001-10-17
US6410569B1 (en) 2002-06-25
AU5515699A (en) 2000-03-14
AU761715B2 (en) 2003-06-05
BG65255B1 (bg) 2007-10-31
ZA200100934B (en) 2002-03-04
CA2341031C (en) 2006-04-04
DE69901840T2 (de) 2003-05-22
SK285105B6 (sk) 2006-06-01
NO20010718L (no) 2001-02-12
SK2362001A3 (en) 2001-09-11
HK1037616A1 (en) 2002-02-15
SI1105386T1 (en) 2002-12-31
CA2341031A1 (en) 2000-03-02
NO319782B1 (no) 2005-09-12
EA004431B1 (ru) 2004-04-29
ES2178896T3 (es) 2003-01-01
ATE219074T1 (de) 2002-06-15
ME00562A (en) 2011-12-20
IL141157A0 (en) 2002-02-10
KR100657835B1 (ko) 2006-12-15
IL141328A0 (en) 2002-03-10
RS50071B (sr) 2009-01-22
US6686379B2 (en) 2004-02-03
PL198801B1 (pl) 2008-07-31
DK1105386T3 (da) 2002-09-30
CZ2001621A3 (cs) 2001-08-15
MXPA01001758A (es) 2002-04-17
NZ509761A (en) 2003-08-29
DE19843413C1 (de) 2000-03-30
EP1105386B1 (en) 2002-06-12
CN1146558C (zh) 2004-04-21
JP2002523411A (ja) 2002-07-30
YU11301A (sh) 2003-12-31
PT1105386E (pt) 2002-11-29
IL141157A (en) 2007-06-17
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
HRP20010117A2 (en) 2002-02-28
HU226618B1 (en) 2009-04-28
US20020188008A1 (en) 2002-12-12
WO2000010995A1 (en) 2000-03-02
ME00562B (me) 2011-12-20
NO20010718D0 (no) 2001-02-12
UA58605C2 (uk) 2003-08-15

Similar Documents

Publication Publication Date Title
HRP20010117B1 (en) Novel salt form of pantoprazole
HRP20010573B1 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
RS49685B (sr) Novi oblik jedinjenja
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HRP20030472B1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
PT1109812E (pt) Pirrolobenzodiazepinas
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
ID27652A (id) Turunan amida yang digunakan sebagai inhibitor produksi sitokina
HN1998000036A (es) Compuesto de pirazina
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
DE69112290D1 (de) Verspritzbare, feuerfeste Zusammensetzung.
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
MX9202413A (es) Composiciones acuosas de citrato de calcio.
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
ATE406431T1 (de) Parfümierte waschmitteltablette
HN1998000102A (es) Composiciones solubilizadas de sertralina
ID27733A (id) Metoksiminofenilasetamida
ATE249204T1 (de) Spray, enthaltend ubichinon qn
ES2159742T3 (es) Procedimiento para la sintesis de benzo(b)tiofenos.
HN1997000013A (es) Compuestos 1,4 dihidropiridina
HN1999000038A (es) Nuevos compuestos fungicidas
BR0110800A (pt) Polipeptìdeos antiangiogênicos
RU2076517C1 (ru) Пищевой краситель
GT199900160A (es) Compuestos plaguicidas de bis-oxima.
GT199900018A (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol (caso ii).

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ALTANA PHARMA AG, DE

PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170713

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20180812